LivingGLP1
Study S001910

Investigating Enteroendocrine Dysfunction, Metabolism, and Response to Liraglutide in Patients With Maturity-onset Diabetes of the Young (MODY)

Registration

Registration
NCT07029009
Study type
INTERVENTIONAL
Phase
PHASE2
Masking
NONE
Status
RECRUITING
Enrollment
50
Start
2025-05-08
Primary completion
2026-08
Lead sponsor
Mansa
Conditions
Maturity Onset Diabetes of the Young
Interventions
DRUG:Liraglutide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Blood sugar control - HbA1C [Baseline and 3 months after study treatment initiation]
  • BMI [baseline, 1 month, 2 months, and final study visit 3 months after study treatment initiation]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.